Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:300611rdf:typepubmed:Citationlld:pubmed
pubmed-article:300611lifeskim:mentionsumls-concept:C0024299lld:lifeskim
pubmed-article:300611lifeskim:mentionsumls-concept:C0521026lld:lifeskim
pubmed-article:300611lifeskim:mentionsumls-concept:C0035820lld:lifeskim
pubmed-article:300611lifeskim:mentionsumls-concept:C0039194lld:lifeskim
pubmed-article:300611lifeskim:mentionsumls-concept:C0205147lld:lifeskim
pubmed-article:300611lifeskim:mentionsumls-concept:C1536403lld:lifeskim
pubmed-article:300611lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:300611pubmed:issue1-2lld:pubmed
pubmed-article:300611pubmed:dateCreated1977-5-25lld:pubmed
pubmed-article:300611pubmed:abstractTextThe cytolyse of lymphoma cells by anti-MSV-CTL requires an H-2 identity on CTL and target cells. It can be limited to D or K antigens. An altered cells hypothesis is the more likely hypothesis in H-2a or H-2d tumour cells. However the D antigen alone is involved in H-2b tumours Arguments are given which supports the existence of Ir genes controlling the formation of CTL against H-2Dd modified by MSV.lld:pubmed
pubmed-article:300611pubmed:languagefrelld:pubmed
pubmed-article:300611pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:300611pubmed:citationSubsetIMlld:pubmed
pubmed-article:300611pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:300611pubmed:statusMEDLINElld:pubmed
pubmed-article:300611pubmed:issn0300-4910lld:pubmed
pubmed-article:300611pubmed:authorpubmed-author:GomardEElld:pubmed
pubmed-article:300611pubmed:authorpubmed-author:DuprezVVlld:pubmed
pubmed-article:300611pubmed:authorpubmed-author:LévyJ PJPlld:pubmed
pubmed-article:300611pubmed:issnTypePrintlld:pubmed
pubmed-article:300611pubmed:volume128lld:pubmed
pubmed-article:300611pubmed:ownerNLMlld:pubmed
pubmed-article:300611pubmed:authorsCompleteYlld:pubmed
pubmed-article:300611pubmed:pagination7-9lld:pubmed
pubmed-article:300611pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:300611pubmed:meshHeadingpubmed-meshheading:300611-A...lld:pubmed
pubmed-article:300611pubmed:meshHeadingpubmed-meshheading:300611-M...lld:pubmed
pubmed-article:300611pubmed:meshHeadingpubmed-meshheading:300611-L...lld:pubmed
pubmed-article:300611pubmed:meshHeadingpubmed-meshheading:300611-C...lld:pubmed
pubmed-article:300611pubmed:meshHeadingpubmed-meshheading:300611-M...lld:pubmed
pubmed-article:300611pubmed:meshHeadingpubmed-meshheading:300611-C...lld:pubmed
pubmed-article:300611pubmed:meshHeadingpubmed-meshheading:300611-H...lld:pubmed
pubmed-article:300611pubmed:meshHeadingpubmed-meshheading:300611-T...lld:pubmed
pubmed-article:300611pubmed:articleTitle[Role of H-2 region in cytolysis of viral induced lymphomas by T lymphocytes].lld:pubmed
pubmed-article:300611pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:300611pubmed:publicationTypeEnglish Abstractlld:pubmed